首页> 外文期刊>Journal of Clinical and Diagnostic Research >Antihyperglycaemic and Antihyperlipidemic Effect of Gymnema Sylvestre in Protracted Diabetes Mellitus in Wistar Rats
【24h】

Antihyperglycaemic and Antihyperlipidemic Effect of Gymnema Sylvestre in Protracted Diabetes Mellitus in Wistar Rats

机译:匙Gym藤对Wistar大鼠长期糖尿病的降血糖和降血脂作用

获取原文
获取外文期刊封面目录资料

摘要

Dysregulation in glucose and lipid metabolism have been observed in the early phases of Diabetes Mellitus (DM) which may further lead to insulin resistance and beta-cell failure. Effective control of these metabolic alterations may delay the clinical onset of diabetes. A proven herbal medication with antihyperglycaemic activity used in the treatment of Diabetes is Gymnema sylvestre (GSE). An extensive study regarding its benefits in treating long standing diabetes and associated dyslipidemia is obligatory.Aim: To study the effects and optimal dosage of a standardized hydroalcoholic leaf extract of GSE on glycaemic and lipid parameters in diabetic rats.Materials and Methods: Wistar rats of either sex were divided into five groups with eight rats in each group. Single dose of Streptozotocin (STZ) (50mg/Kg body weight) was used to induce DM. The diabetic rats were treated with two oral doses of the GSE at 1g and 2.5 g/kg body wt/day and Glibenclamide (Glb) (500 μg/kg body weight) for a period of 16 weeks. Fasting Blood Glucose (FBG) was checked at day-1 and at the end of 16 weeks. Plasma glycated Haemoglobin (HbA1c), serum insulin, serum Triacylglycerol (TG), Total Cholesterol (TC) and High Density Lipoprotein fraction of Cholesterol (HDL-C) were measured at the end of the study. Statistical analysis was done using the software SPSS-20.Results: Significant decrease in FBG in a dose dependent manner was observed along with increase in serum insulin and decrease in HbA1c levels. Treatment with GSE decreased TG levels significantly and was comparable with Glb. Improvement in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was not significant, but that of Triglyceride Glucose Index (TGI) was significant. GSE at the dose of 2.5g/kg body weight showed a positive correlation between HOMA-IR and TGI (p=0.01) and was comparable with the results of Glb.Conclusion: GSE had a sustained and dose dependent effect in improving glycaemic parameters and TG in diabetic rats of protracted duration. Insulin resistance did not vary significantly from the diabetic control rats.
机译:在糖尿病(DM)的早期阶段就观察到葡萄糖和脂质代谢失调,这可能进一步导致胰岛素抵抗和β细胞衰竭。对这些代谢改变的有效控制可能会延迟糖尿病的临床发作。 Gymnema sylvestre(GSE)是公认的具有抗高血糖活性的草药,可用于治疗糖尿病。 目的:研究标准的GSE的水醇叶提取物对糖尿病大鼠血糖和脂质参数的影响和最佳剂量。材料方法:将雄性Wistar大鼠分为五组,每组八只。单剂量的链脲佐菌素(STZ)(50mg / Kg体重)用于诱导DM。用两个口服剂量的GSE(分别为1g和2.5 g / kg体重/天)和格列本脲(Glb)(500μg/ kg体重)治疗糖尿病大鼠,持续16周。在第1天和16周结束时检查空腹血糖(FBG)。在研究结束时测量血浆糖化血红蛋白(HbA1c),血清胰岛素,血清三酰甘油(TG),总胆固醇(TC)和胆固醇的高密度脂蛋白分数(HDL-C)。使用软件SPSS-20进行统计分析。结果:观察到FBG呈剂量依赖性显着下降,同时血清胰岛素增加和HbA1c水平降低。 GSE治疗可显着降低TG水平,与Glb相当。胰岛素抵抗稳态模型评估(HOMA-IR)的改善不显着,但甘油三酸酯葡萄糖指数(TGI)的改善显着。剂量为2.5g / kg体重的GSE在HOMA-IR和TGI之间呈正相关(p = 0.01),与Glb的结果相当。结论:GSE在改善病情方面具有持续且剂量依赖性的作用糖尿病持续时间的血糖参数和TG糖尿病对照大鼠的胰岛素抵抗没有显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号